Skip to main content


Aspects of early diagnosis, treatment, disease activity, pathogenesis, prognosis, biomarkers, comorbidity, compliance, adherence and quality of life in:

In clinically well characterised cohorts/trials:
Inception and trans-sectional cohorts
Investigator initiated trials

Randomized and open treatment strategy studies with synthetic and biological DMARD (Disease Modifying Anti Rheumatic Drugs) as well as training strategies.

Sidst opdateret: 01.04.2019